US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BOLD

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
11/04/2024	07:00	Business Wire	Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications	NASDAQ:BOLD	Boundless Bio Inc
08/04/2024	07:00	Business Wire	Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024	NASDAQ:BOLD	Boundless Bio Inc
14/02/2020	16:23	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
11/02/2020	15:41	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BOLD	Boundless Bio Inc
27/01/2020	08:38	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:BOLD	Boundless Bio Inc
21/01/2020	05:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BOLD	Boundless Bio Inc
03/12/2019	18:13	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.	NASDAQ:BOLD	Boundless Bio Inc
02/12/2019	17:01	Business Wire	Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics	NASDAQ:BOLD	Boundless Bio Inc
26/11/2019	15:01	Business Wire	Audentes Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:BOLD	Boundless Bio Inc
12/11/2019	16:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
07/11/2019	16:18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BOLD	Boundless Bio Inc
07/11/2019	15:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
07/11/2019	15:01	Business Wire	Audentes Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:BOLD	Boundless Bio Inc
31/10/2019	06:00	Business Wire	Audentes Therapeutics to Release Third Quarter 2019 Financial Results and Provide Corporate Update on Thursday, November 7, 2...	NASDAQ:BOLD	Boundless Bio Inc
05/10/2019	06:01	Business Wire	Audentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked M...	NASDAQ:BOLD	Boundless Bio Inc
04/10/2019	17:00	Business Wire	Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:BOLD	Boundless Bio Inc
30/09/2019	07:00	Business Wire	Audentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including Ne...	NASDAQ:BOLD	Boundless Bio Inc
23/08/2019	15:03	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:BOLD	Boundless Bio Inc
06/08/2019	15:01	PR Newswire (US)	Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:BOLD	Boundless Bio Inc
30/07/2019	07:00	PR Newswire (US)	Audentes Therapeutics to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 6, 201...	NASDAQ:BOLD	Boundless Bio Inc
17/07/2019	15:25	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:BOLD	Boundless Bio Inc
29/05/2019	15:01	PR Newswire (US)	Audentes Therapeutics Announces Changes to Senior Management Team	NASDAQ:BOLD	Boundless Bio Inc
13/05/2019	05:04	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:BOLD	Boundless Bio Inc
08/05/2019	07:00	PR Newswire (US)	Audentes Therapeutics to Participate in the Bank of America Merrill Lynch 2019 Health Care Conference	NASDAQ:BOLD	Boundless Bio Inc
07/05/2019	15:01	PR Newswire (US)	Audentes Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:BOLD	Boundless Bio Inc
01/05/2019	13:15	PR Newswire (US)	Audentes Therapeutics Presents New Positive Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 for X-linked Myotubular M...	NASDAQ:BOLD	Boundless Bio Inc
30/04/2019	07:00	PR Newswire (US)	Audentes Therapeutics to Release First Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, May 7, 2019	NASDAQ:BOLD	Boundless Bio Inc
26/04/2019	15:38	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:BOLD	Boundless Bio Inc
26/04/2019	15:37	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BOLD	Boundless Bio Inc
23/04/2019	07:00	PR Newswire (US)	Audentes Therapeutics Announces Launch of New State-of-the-Art Internal cGMP Plasmid Manufacturing Facility	NASDAQ:BOLD	Boundless Bio Inc

Showing the most relevant articles for your search:NASDAQ:BOLD

1 2 3 4 Próxima >

US Dollar vs MXN

Gold vs US Dollar

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones